× Industry Reports Services Press Release Contact us About us

Asia Pacific Stents Market Size By Material (Metal, Polymer), By Product (Vascular Stents {Coronary Stents [Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents], Peripheral Stents [Iliac, Femoral-popliteal, Renal, Carotid], Neurovascular Stents}, Non-Vascular Stents), By Type (Self-expandable, Balloon-expandable), By End-use (Hospital, Ambulatory Surgical Centers), Industry Analysis Report, Country Outlook (Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, Philippines, Indonesia), Application Potential, Competitive Market Share & Forecast, 2021 - 2027
Published Date: February 2021 | Publisher: Graphical Research Report ID: GR1644 | Delivery : PDF  Request Free Sample

Report Content

Chapter 1.  Methodology

1.1. Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters      

1.2. Data sources

1.3. References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.  Executive Summary

2.1. Asia Pacific stents industry summary, 2016 – 2027

2.1.1.  Country trends

2.1.2.  Product trends

2.1.3.  Material trends

2.1.4.  Type trends

2.1.5.  End-use trends

Chapter 3.  Industry Insights

3.1. Industry segmentation

3.2. Industry outlook, 2016 - 2027

3.3. Major factor analysis

3.3.1.  Drivers

3.3.1.1.  Increasing prevalence of cardiovascular disease across the Asia Pacific region

3.3.1.2.  Rising demand for minimally invasive procedures

3.3.1.3.    Unhealthy and sedentary lifestyle

3.3.1.4.    Increasing geriatric population

3.3.2. Industry pitfall and challenges

3.3.2.1.  Stent failure and recall

3.3.2.2.  Stringent regulatory approvals 

3.4. COVID-19 impact analysis

3.5. Porter’s analysis

3.6. Competitive review, 2020

3.7. PEST analysis

Chapter 4. Asia Pacific Stents Market, By Product

4.1. Key trends in Asia Pacific Stents market, by product

4.2. Vascular stents

4.2.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.2.  Coronary stents

4.2.2.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.2.2.    Bare metal stents

4.2.2.2.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.2.3. Drug eluting stents

4.2.2.3.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.2.4. Bioresorbable stents

4.2.2.4.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.3.  Peripheral stents

4.2.3.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.3.2. Iliac stents

4.2.3.2.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.3.3. Femoral-popliteal stents

4.2.3.3.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.3.4. Renal stents

4.2.3.4.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.3.5. Carotid stents

4.2.3.5.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.2.4.  Neurovascular stents

4.2.4.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

4.3. Non-vascular stents

4.3.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

Chapter 5. Asia Pacific Stents Market, By Material

5.1. Key trends in Asia Pacific Stents market, by material

5.2. Metal

5.2.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

5.3. Polymer

5.3.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

Chapter 6. Asia Pacific Stents Market, By Type

6.1. Key trends in Asia Pacific Stents market, by type

6.2. Self-expandable stents

6.2.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

6.3. Balloon expandable stents

6.3.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

Chapter 7. Asia Pacific Stents Market, By End-use

7.1. Key trends in Asia Pacific Stents market, by material

7.2. Hospitals

7.2.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

7.3. Ambulatory surgical centers

7.3.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

7.4. Others

7.4.1.  Market estimates and forecast, by country, 2016 – 2027 (USD Million & Units)

Chapter 8. Asia Pacific Stents Market, By Country

8.1. Key trends in Asia Pacific stents market, by country

8.2. Japan

8.2.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.2.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.2.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.2.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.2.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.2.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.2.1.4.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.3. China

8.3.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.3.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.3.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.3.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.3.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.3.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.3.1.4.    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.4. India

8.4.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.4.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.4.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.4.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.4.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.4.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.4.1.4.    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.5. Australia

8.5.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.5.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.5.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.5.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.5.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.5.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.5.1.4.    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.6. Singapore

8.6.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.6.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.6.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.6.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.6.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.6.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.6.1.4.    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.7. South Korea

8.7.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.7.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.7.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.7.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.7.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.7.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.7.1.4.    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.8. Malaysia

8.8.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.8.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.8.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.8.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.8.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.8.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.8.1.4.    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.9. Thailand

8.9.1.   Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.9.1.1.  Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.9.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.9.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.9.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.9.1.3.  Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.9.1.4.    Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.10. Philippines

8.10.1. Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.10.1.1. Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.10.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.10.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.10.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.10.1.3. Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.10.1.4. Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

8.11. Indonesia

8.11.1. Market estimates and forecast, by product, 2016 – 2027 (USD Million & Units)

8.11.1.1. Market estimates and forecast, by vascular stents, 2016 – 2027 (USD Million & Units)

8.11.1.1.1. Market estimates and forecast, by coronary stents, 2016 – 2027 (USD Million & Units)

8.11.1.1.2. Market estimates and forecast, by peripheral stents, 2016 – 2027 (USD Million & Units)

8.11.1.2. Market estimates and forecast, by material, 2016 – 2027 (USD Million & Units)

8.11.1.3. Market estimates and forecast, by type, 2016 – 2027 (USD Million & Units)

8.11.1.4.  Market estimates and forecast, by end-use, 2016 – 2027 (USD Million & Units)

Chapter 9.  Company Profiles

9.1. Abbott Laboratories

9.1.1.   Business overview

9.1.2.  Financial data

9.1.3.  Product landscape

9.1.4.  Strategic outlook

9.2. B. Braun Melsungen AG

9.2.1.   Business overview

9.2.2.  Financial data

9.2.3.  Product landscape

9.2.4.  Strategic outlook

9.3. Biosensors International Group

9.3.1.   Business overview

9.3.2.  Financial data

9.3.3.  Product landscape

9.3.4.  Strategic outlook

9.4. Biotronik SE & Co. KG

9.4.1.   Business overview

9.4.2.  Financial data

9.4.3.  Product landscape

9.4.4.  Strategic outlook

9.5. Boston Scientific Corporation

9.5.1.   Business overview

9.5.2.  Financial data

9.5.3.  Product landscape

9.5.4.  Strategic outlook

9.6. C R Bard

9.6.1.   Business overview

9.6.2.  Financial data

9.6.3.  Product landscape

9.6.4.  Strategic outlook

9.7. Elixir Medical Corporation

9.7.1.   Business overview

9.7.2.  Financial data

9.7.3.  Product landscape

9.7.4.  Strategic outlook

9.8. Medtronic Plc

9.8.1.   Business overview

9.8.2.  Financial data

9.8.3.  Product landscape

9.8.4.  Strategic outlook

9.9. Meril Life Science

9.9.1.   Business overview

9.9.2.  Financial data

9.9.3.  Product landscape

9.9.4.  Strategic outlook

9.10.    MicroPort Scientific Corporation

9.10.1. Business overview

9.10.2.          Financial data

9.10.3.          Product landscape

9.10.4.          Strategic outlook

9.11.    Stryker

9.11.1. Business overview

9.11.2.          Financial data

9.11.3.          Product landscape

9.11.4.          Strategic outlook

9.12.    Terumo Corporation

9.12.1. Business overview

9.12.2.          Financial data

9.12.3.          Product landscape

9.12.4.          Strategic outlook

9.13.    Veryan Medical Limited

9.13.1. Business overview

9.13.2.          Financial data

9.13.3.          Product landscape

9.13.4.          Strategic outlook

9.14.    W.L Gore & Associates

9.14.1. Business overview

9.14.2.          Financial data

9.14.3.          Product landscape

9.14.4.          Strategic outlook

 


Premium Report

Have questions?
  • Inquire Before Buying
  • Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

     1-800-986-6917

     [email protected]